{
    "eid": "2-s2.0-85116756438",
    "title": "Leveraging knowledge of Asian herbal medicine and its active compounds as COVID-19 treatment and prevention",
    "cover-date": "2022-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Asian",
        "COVID-19",
        "Herbal medicine",
        "Plant bioactive compounds",
        "Prevention",
        "Treatment"
    ],
    "authors": [
        "Desy Liana",
        "Anuchit Phanumartwiwath"
    ],
    "citedby-count": 10,
    "ref-count": 73,
    "ref-list": [
        "Chinese herbal medicine: fighting SARS-CoV-2 infection on all fronts",
        "Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: a mini-review of SARS-CoV-2 therapeutic targets",
        "COVID-19: the vasculature unleashed",
        "The scientific foundation of Chinese herbal medicine against COVID-19",
        "COVID-19 Pandemic: a case for phytomedicines",
        "Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial",
        "What do we know about China\u2019s covid-19 vaccines?",
        "Effectiveness of the Pfizer-BioNTech COVID-19 vaccine among residents of two skilled nursing facilities experiencing COVID-19 outbreaks\u2014Connecticut, December 2020\u2013February 2021",
        "The advisory committee on immunization practices\u2019 interim recommendation for use of moderna COVID-19 vaccine\u2014United States, December 2020",
        "Oxford\u2013AstraZeneca COVID-19 vaccine efficacy",
        "The Johnson & Johnson Vaccine for COVID-19",
        "Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant",
        "A comprehensive review of the global efforts on COVID-19 vaccine development",
        "COVID-19: vaccine development updates",
        "Natural product drug discovery in the next millennium",
        "Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?",
        "The application of Chinese medicine to novel drug discovery",
        "Traditional herbal medicine for the prevention and treatment of cold and flu in the autumn of 2020, overlapped with COVID-19",
        "Chinese herbal medicine for SARS and SARS-CoV-2 treatment and prevention, encouraging using herbal medicine for COVID-19 outbreak",
        "High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents",
        "The antiviral, anti-inflammatory effects of natural medicinal herbs and mushrooms and SARS-CoV-2 infection",
        "Glycyrrhizin effectively inhibits SARS-CoV-2 replication by inhibiting the viral main protease",
        "COVID-19 drug discovery using intensive approaches",
        "Therapeutic strategies against COVID-19 and structural characterization of SARS-CoV-2: a review",
        "Exploring sodium glucose co-transporter-2 (SGLT2) inhibitors for organ protection in COVID-19",
        "Quercetin and its metabolites inhibit recombinant human angiotensin-converting enzyme 2 (ACE2) activity",
        "Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion",
        "Tea polyphenols EGCG and theaflavin inhibit the activity of SARS-CoV-2 3CL-protease in vitro",
        "Na+/K+-ATPase as a target of cardiac glycosides for the treatment of SARS-CoV-2 infection",
        "Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component Andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives",
        "Broad-spectrum antiviral properties of andrographolide",
        "Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor",
        "Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage",
        "Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata",
        "Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease",
        "Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro",
        "Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro",
        "Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients",
        "Baicalein and baicalin inhibit SARS-CoV-2 RNA-dependent-RNA polymerase",
        "Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs",
        "Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19",
        "Classical drug digitoxin inhibits influenza cytokine storm, with implications for COVID-19 therapy",
        "Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration into human lung cells",
        "Use of and attitudes towards herbal medicine during the COVID-19 pandemic: a cross-sectional study in Vietnam",
        "Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs",
        "Some home remedies used for treatment of COVID-19 in Bangladesh",
        "Dietary therapy and herbal medicine for COVID-19 prevention: a review and perspective",
        "Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)",
        "Therapeutic efficacy of pudilan xiaoyan oral liquid (PDL) for COVID-19 in vitro and in vivo",
        "A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19)",
        "Potentiality and possibility of medicinal plants on ayurvedic principle in prevention and treatment of COVID-19",
        "Home remedies for COVID-19 treatment in Gazipur district, Bangladesh",
        "Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease",
        "Reynoutria rhizomes as a natural source of SARS-CoV-2 Mpro inhibitors-molecular docking and in vitro study",
        "Identification of natural compounds with antiviral activities against SARS-associated coronavirus",
        "Anti-SARS-CoV-2 potential of artemisinins in vitro",
        "Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches",
        "Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-\u03baB) signaling pathway",
        "Allicin inhibits SARS-CoV-2 replication and abrogates the antiviral host response in the Calu-3 proteome",
        "Olive-derived triterpenes suppress SARS COV-2 main protease: a promising scaffold for future therapeutics",
        "Cnicin as an anti-SARS-CoV-2: an integrated in silico and in vitro approach for the rapid identification of potential COVID-19 therapeutics",
        "Kobophenol A inhibits binding of host ACE2 receptor with spike RBD domain of SARS-CoV-2, a lead compound for blocking COVID-19",
        "Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: inhibition potentials, covalent binding sites and inhibitory mechanisms",
        "Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cultured Vero cells",
        "The natural stilbenoid (\u2013)-hopeaphenol inhibits cellular entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7 and B.1.351 variants"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "College of Public Health Science, Chulalongkorn University"
    ]
}